Target intelligence / Profile preview

AMMECR nuclear protein 1 (AMMECR1)

Target
AMMECR1
Molecular classification
Nuclear protein, Chromosomal region gene, Putative DNA/RNA-binding protein (RAGNYA fold)—suggesting possible nucleic acid interaction, Other
01

Overview

AMMECR nuclear protein 1 is a highly conserved nuclear protein encoded by the *AMMECR1* gene on Xq22.3. This protein is defined by a RAGNYA fold, suggesting potential interaction with nucleic acids or nucleotides, and is thought to participate in fundamental cellular processes within the nucleus. Mutations, deletions, or loss-of-function variants of AMMECR1 are implicated in a contiguous gene deletion syndrome characterized by Alport syndrome, intellectual disability, midface hypoplasia, elliptocytosis, cardiac and skeletal malformations, and hearing loss. AMMECR1 may play a role in regulating cell cycle progression and growth; for example, downregulation in lung cancer cell lines suppresses proliferation and induces apoptosis. Despite conservation and disease association, its precise molecular function is unknown and it is not considered a therapeutic drug target at this time[1][2][5][6].

Other names
AMME syndrome candidate gene 1 proteinAMMERC1MFHIENnuclear protein AMMECR1AMMECR nuclear protein 1
02

Biological functions

Modulation of cell cycle progressionCellular growth regulationLikely involved in nuclear processes such as transcription, replication, repair, or translation machinery (exact function remains unknown)
03

Disease associations

Developmental syndromes (AMME syndrome)Growth, bone and cardiac abnormalitiesHearing loss, cleft palate, congenital hip dysplasia (in female carriers)Lung cancer (downregulation suppresses proliferation and increases apoptosis in cell models)Other

Beyond the preview

Go deeper on AMMECR nuclear protein 1 (AMMECR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMMECR nuclear protein 1 (AMMECR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call